Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Frontiers in Endocrinology|February 23, 2024
Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System databaseWei Chen, Peishan Cai, Wenbin Zou, et al.
Expert Opinion on Drug Safety|October 16, 2024
Diabetic adverse events associated with three commonly used statins: a disproportionality analysis based on the FDA adverse event reporting system databaseBin Deng, Shijun Li, Ruxu You, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 23, 2022
Prophylactic transanal drainage tube placement for preventing anastomotic leakage after anterior resection for rectal cancer: A meta-analysisChenchen Guo, Zhiwen Fu, Xin Qing, et al.
Expert Opinion on Drug Safety|April 15, 2025
A disproportionality analysis of interstitial lung disease associated with drug therapy in spontaneous adverse event reportsJiao Yuan, Zhiping Li, Meifang Ye, et al.
Signal Transduction and Targeted Therapy|March 23, 2022
Antibody drug conjugate: the "biological missile" for targeted cancer therapyZhiwen Fu, Shijun Li, Sifei Han, et al.
Eclinicalmedicine|March 27, 2023
Corrigendum to "Treatment-related adverse events associated with HER2-Targeted antibody-drug conjugates in clinical trials: a systematic review and meta-analysis" [EClinicalMedicine 55 (2022) 101795]Zhiwen Fu, Jinmei Liu, Shijun Li, et al.
Natural Product Research|February 5, 2015
Identification and structural elucidation of steroidal saponins from the root of Paris polyphylla by HPLC-ESI-QTOF-MS/MSYun Ling, Zhiwen Fu, Qing Zhang, et al.
Expert Opinion on Drug Safety|July 29, 2023
Gender differences in adverse events related to Osimertinib: a real-world pharmacovigilance analysis of FDA adverse event reporting systemZhiping Li, Wenbin Zou, Jiao Yuan, et al.
BMC Pharmacology & Toxicology|January 29, 2025
Musculoskeletal adverse events associated with CDK4/6 inhibitors: a real-world study using FDA Adverse Event Reporting System (FAERS) databaseZhenlin Chen, Zhiwen Fu, Nu Zhang, et al.
Eclinicalmedicine|January 30, 2023
Treatment-related adverse events associated with HER2-Targeted antibody-drug conjugates in clinical trials: a systematic review and meta-analysisZhiwen Fu, Jinmei Liu, Shijun Li, et al.
Pageof 5